Stryker acquires AVS for up to USD 835M
Article excerpt
Highlighted: the sentence this signal was extracted from
Global medical technology company Stryker has acquired Amplitude Vascular Systems (AVS), a University of Michigan startup that developed technology to treat arterial calcification, for up to $835 million, according to a June 25 announcement. The deal brings the AVS Pulse IVL System under the umbrella of the global medical technology company headquartered in Portage, about 100 miles west of Ann Arbor. The acquisition aims to expand access to the treatment for patients with calcified arterial disease, a leading contributor to cardiovascular disease. When calcium hardens within arteries, it restricts blood flow and increases the risk of heart attack and stroke. AVS developed the Pulse IVL System, which uses hydraulic pulse waves delivered through a balloon catheter to break apart calcium buildups within arteries. After fragmenting the calcium, the balloon expands the artery to restore blood flow. "When arteries become hardened by calcium, it can make treatment more challenging and limit how well we're able to restore blood flow," Dr. Hitinder Gurm, Park Willis III Legacy Professor in Cardiovascular Medicine, professor of internal medicine and chief medical officer at UM Health, said in the announcement. "What's promising about Pulse IVL is that it's designed to break up calcium in a way that helps the artery open more effectively and potentially improve outcomes for patients...
Keep reading with a free account
The rest of this article, and every signal for Stryker, is in your free account.
